Risk factor
Poor trading liquidity
Profitability factor
Very strong margins and returns
About
Established in 1998 and headquartered in New Taipei City, Taiwan, TaiDoc Technology Corporation develops and globally distributes a wide array of medical devices. Their offerings encompass in vitro diagnostics, such as advanced blood glucose and multi-parameter monitoring systems, point-of-care testing equipment, and lancet devices, alongside specialized veterinary health products like blood glucose, calcium, and ketone meters for animals. The company also manufactures general medical equipment, including nebulizers, thermometers, blood pressure and vital sign monitors, and pulse oximeters. Additionally, TaiDoc provides remote monitoring solutions for telehealth, complete with smartphone applications, and produces COVID-19 antigen rapid test kits. Complementing its product portfolio, the company offers essential services in areas like regulatory guidance, clinical recommendations, engineering support, and manufacturing system development.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBITDA, tradin